Serine-associated one-carbon metabolic reprogramming: a new anti-cancer therapeutic strategy
- PMID: 37664062
- PMCID: PMC10471886
- DOI: 10.3389/fonc.2023.1184626
Serine-associated one-carbon metabolic reprogramming: a new anti-cancer therapeutic strategy
Abstract
Tumour metabolism is a major focus of cancer research, and metabolic reprogramming is an important feature of malignant tumours. Serine is an important non-essential amino acid, which is a main resource of one-carbon units in tumours. Cancer cells proliferate more than normal cells and require more serine for proliferation. The cancer-related genes that are involved in serine metabolism also show changes corresponding to metabolic alterations. Here, we reviewed the serine-associated one-carbon metabolism and its potential as a target for anti-tumour therapeutic strategies.
Keywords: SERINE; immunotherapy; metabolism reprogramming; molecular targeted therapy; one-carbon units.
Copyright © 2023 Zhang, Bai, Gong, Wang, Cheng, Zhao and Xiong.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
Publication types
LinkOut - more resources
Full Text Sources
